Eva Littringer is Co-founder and inventor at RevIVe Medtech GmbH and Oncofuse GmbH, and serves as Associate Director of Science & Technology at Novartis, where she operates at the intersection of pharmaceutical innovation, medical device development, and entrepreneurial execution to translate breakthrough ideas into real-world patient impact.Her expertise spans small molecule and biologics development within large global pharmaceutical organizations, combined with hands-on experience in pharmaceutical development and regulated medical device innovation—from concept design through validation, clinical translation, and commercialization. She specializes in designing scalable innovation processes, integrating science, engineering, regulatory strategy, and business to accelerate the delivery of high-impact healthcare solutions.